Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDTA Eye Drops in Band Keratopathy
NCT03985371Phase 1Completed
- Sponsor
- University of Rochester
- Start
- Jun 2020
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ethylenediaminetetraacetic acid in band keratopathy (BSK), sponsored by University of Rochester. Primary endpoints: Changes of the Cornea at 180 days, Visual Acuity at 180 days and 1 more. Started Jun 2020; status: completed.
02
Drugs
ethylenediaminetetraacetic acid
03
Conditions
band keratopathy (BSK)
Beyond the preview
Go deeper on NCT03985371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03985371.